Summary
This report studies the Antibody-drug Conjugates market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Antibody-drug Conjugates market by product type and application/end industries.
The global Antibody-drug Conjugates market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Antibody-drug Conjugates.
United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.
Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Antibody-drug Conjugates in these regions, from 2013 to 2025 (forecast), covering
United States
North America
Europe
Asia-Pacific
South America
Middle East and Africa
The major players in global and United States market, including
ImmunoGen
Seattle Genetics
Roche
Takeda
On the basis of product, the market is primarily split into
Adcetris
Kadcyla
On the basis on the end users/application, this report covers
Breast Cancer
Lymphoma
Table of Contents
2018-2025 Antibody-drug Conjugates Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
1 Methodology and Data Source
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
1.2.1 Secondary Sources
1.2.2 Primary Sources
1.3 Disclaimer
2 Antibody-drug Conjugates Market Overview
2.1 Antibody-drug Conjugates Product Overview
2.2 Antibody-drug Conjugates Market Segment by Type
2.2.1 Adcetris
2.2.2 Kadcyla
2.3 Global Antibody-drug Conjugates Product Segment by Type
2.3.1 Global Antibody-drug Conjugates Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
2.3.2 Global Antibody-drug Conjugates Sales (K Pcs) and Market Share (%) by Type (2013-2018)
2.3.3 Global Antibody-drug Conjugates Revenue (Million USD) and Market Share (%) by Type (2013-2018)
2.3.4 Global Antibody-drug Conjugates Price (USD/Pcs) by Type (2013-2018)
2.4 United States Antibody-drug Conjugates Product Segment by Type
2.4.1 United States Antibody-drug Conjugates Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
2.4.2 United States Antibody-drug Conjugates Sales (K Pcs) and Market Share by Type (2013-2018)
2.4.3 United States Antibody-drug Conjugates Revenue (Million USD) and Market Share by Type (2013-2018)
2.4.4 United States Antibody-drug Conjugates Price (USD/Pcs) by Type (2013-2018)
3 Antibody-drug Conjugates Application/End Users
3.1 Antibody-drug Conjugates Segment by Application/End Users
3.1.1 Breast Cancer
3.1.2 Lymphoma
3.2 Global Antibody-drug Conjugates Product Segment by Application
3.2.1 Global Antibody-drug Conjugates Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
3.2.2 Global Antibody-drug Conjugates Sales (K Pcs) and Market Share (%) by Application (2013-2018)
3.3 United States Antibody-drug Conjugates Product Segment by Application
3.3.1 United States Antibody-drug Conjugates Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
3.3.2 United States Antibody-drug Conjugates Sales (K Pcs) and Market Share (%) by Application (2013-2018)
4 Antibody-drug Conjugates Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Antibody-drug Conjugates Market Size and CAGR by Regions (2013, 2017 and 2025)
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.1.7 United States
4.2 Global Antibody-drug Conjugates Sales and Revenue by Regions
4.2.1 Global Antibody-drug Conjugates Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
4.2.2 Global Antibody-drug Conjugates Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
4.2.3 Global Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.4 North America Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.5 Europe Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.6 Asia-Pacific Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.7 South America Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
4.2.8 Middle East and Africa Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.9 United States Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
5 Global Antibody-drug Conjugates Market Competition by Players/Manufacturers
5.1 Global Antibody-drug Conjugates Sales (K Pcs) and Market Share by Players (2013-2018)
5.2 Global Antibody-drug Conjugates Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Antibody-drug Conjugates Average Price (USD/Pcs) by Players (2013-2018)
5.4 Global Top Players Antibody-drug Conjugates Manufacturing Base Distribution, Sales Area, Product Types
5.5 Antibody-drug Conjugates Market Competitive Situation and Trends
5.5.1 Antibody-drug Conjugates Market Concentration Rate
5.5.2 Global Antibody-drug Conjugates Market Share (%) of Top 3 and Top 5 Players
5.5.3 Mergers & Acquisitions, Expansion
6 United States Antibody-drug Conjugates Market Competition by Players/Manufacturers
6.1 United States Antibody-drug Conjugates Sales (K Pcs) and Market Share by Players (2013-2018)
6.2 United States Antibody-drug Conjugates Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Antibody-drug Conjugates Average Price (USD/Pcs) by Players (2013-2018)
6.4 United States Antibody-drug Conjugates Market Share (%) of Top 3 and Top 5 Players
7 Antibody-drug Conjugates Players/Manufacturers Profiles and Sales Data
7.1 ImmunoGen
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Antibody-drug Conjugates Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 ImmunoGen Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.1.4 Main Business/Business Overview
7.2 Seattle Genetics
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Antibody-drug Conjugates Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Seattle Genetics Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.2.4 Main Business/Business Overview
7.3 Roche
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Antibody-drug Conjugates Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Roche Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.3.4 Main Business/Business Overview
7.4 Takeda
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Antibody-drug Conjugates Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Takeda Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.4.4 Main Business/Business Overview
8 Antibody-drug Conjugates Manufacturing Cost, Industrial Chain and Downstream Buyers
8.1 Antibody-drug Conjugates Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Antibody-drug Conjugates Industrial Chain Analysis
8.4 Downstream Buyers in United States
9 Marketing Strategy Analysis, Distributors and Market Effect Factors
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
9.3.1 Economic/Political Environmental Change
9.3.2 Downstream Demand Change
9.3.3 Technology Progress in Related Industry
9.3.4 Substitutes Threat
10 Global Antibody-drug Conjugates Market Forecast
10.1 Global Antibody-drug Conjugates Sales, Revenue Forecast (2018-2025)
10.1.1 Global Antibody-drug Conjugates Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
10.1.2 Global Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Antibody-drug Conjugates Market Forecast
10.2.1 United States Antibody-drug Conjugates Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
10.2.2 United States Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Antibody-drug Conjugates Forecast by Regions
10.3.1 North America Antibody-drug Conjugates Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.2 Europe Antibody-drug Conjugates Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.3 Asia-Pacific Antibody-drug Conjugates Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.4 South America Antibody-drug Conjugates Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.5 Middle East and Africa Antibody-drug Conjugates Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.4 Antibody-drug Conjugates Forecast by Type
10.4.1 Global Antibody-drug Conjugates Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.4.2 United States Antibody-drug Conjugates Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Antibody-drug Conjugates Forecast by Application
10.5.1 Global Antibody-drug Conjugates Sales (K Pcs) Forecast by Application (2018-2025)
10.5.2 United States Antibody-drug Conjugates Sales (K Pcs) Forecast by Application (2018-2025)
11 Research Findings and Conclusion
List of Tables and Figures
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Antibody-drug Conjugates Product Picture
Figure Global Antibody-drug Conjugates Revenue (Million USD) Status and Outlook (2013-2025)
Figure United States Antibody-drug Conjugates Revenue (Million USD) Status and Outlook (2013-2025)
Figure Product Picture of Adcetris
Table Major Players of Adcetris
Figure Global Adcetris Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Kadcyla
Table Major Players of Kadcyla
Figure Global Kadcyla Sales (K Pcs) and Growth Rate (%)(2013-2018)
Table Global Antibody-drug Conjugates Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table Global Antibody-drug Conjugates Sales (K Pcs) by Type (2013-2018)
Table Global Antibody-drug Conjugates Sales Share (%) by Type (2013-2018)
Figure Global Antibody-drug Conjugates Sales Market Share (%) by Type (2013-2018)
Figure Global Antibody-drug Conjugates Sales Market Share (%) by Type in 2017
Table Global Antibody-drug Conjugates Revenue (Million USD) by Type (2013-2018)
Table Global Antibody-drug Conjugates Revenue Share (%) by Type (2013-2018)
Figure Global Antibody-drug Conjugates Revenue Share (%) by Type (2013-2018)
Figure 2017 Global Antibody-drug Conjugates Revenue Market Share (%) by Type
Table Global Antibody-drug Conjugates Price (USD/Pcs) by Type (2013-2018)
Table United States Antibody-drug Conjugates Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table United States Antibody-drug Conjugates Sales (K Pcs) by Type (2013-2018)
Table United States Antibody-drug Conjugates Sales Share (%) by Type (2013-2018)
Figure United States Antibody-drug Conjugates Sales Market Share (%) by Type (2013-2018)
Figure United States Antibody-drug Conjugates Sales Market Share (%) by Type in 2017
Table United States Antibody-drug Conjugates Revenue (Million USD) by Type (2013-2018)
Table United States Antibody-drug Conjugates Revenue Share (%) by Type (2013-2018)
Figure United States Antibody-drug Conjugates Revenue Share (%)by Type (2013-2018)
Figure 2017 United States Antibody-drug Conjugates Revenue Market Share (%) by Type
Table United States Antibody-drug Conjugates Price (USD/Pcs) by Type (2013-2018)
Figure Breast Cancer Examples
Figure Lymphoma Examples
Table Global Antibody-drug Conjugates Sales (K Pcs) Comparison by Application (2013-2025)
Table Global Antibody-drug Conjugates Sales (K Pcs) by Application (2013-2018)
Table Global Antibody-drug Conjugates Sales Share (%) by Application (2013-2018)
Figure Global Antibody-drug Conjugates Sales Market Share (%) by Application (2013-2018)
Figure Global Antibody-drug Conjugates Sales Market Share (%) by Application in 2017
Table United States Antibody-drug Conjugates Sales (K Pcs) Comparison by Application (2013-2025)
Table United States Antibody-drug Conjugates Sales (K Pcs) by Application (2013-2018)
Table United States Antibody-drug Conjugates Sales Share (%) by Application (2013-2018)
Figure United States Antibody-drug Conjugates Sales Market Share (%) by Application (2013-2018)
Figure United States Antibody-drug Conjugates Sales Market Share (%) by Application in 2017
Table Global Antibody-drug Conjugates Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
Figure North America Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure United States Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global Antibody-drug Conjugates Sales (K Pcs) by Regions (2013-2018)
Table Global Antibody-drug Conjugates Sales Market Share (%) by Regions (2013-2018)
Figure Global Antibody-drug Conjugates Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Antibody-drug Conjugates Sales Market Share (%) by Regions
Figure 2017 United States Antibody-drug Conjugates Sales Market Share (%) in Global Market
Table Global Antibody-drug Conjugates Revenue (Million USD) by Regions (2013-2018)
Table Global Antibody-drug Conjugates Revenue Market Share (%) by Regions (2013-2018)
Figure Global Antibody-drug Conjugates Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Antibody-drug Conjugates Revenue Market Share (%) by Regions
Figure 2017 United States Antibody-drug Conjugates Revenue Market Share (%) in Global Market
Table Global Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table North America Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Europe Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Asia-Pacific Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table South America Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Middle East and Africa Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table United States Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Global Antibody-drug Conjugates Sales (K Pcs) of Key Players (2013-2018)
Table Global Antibody-drug Conjugates Sales Share (%) by Players (2013-2018)
Figure 2017 Global Antibody-drug Conjugates Sales Share (%) by Players
Figure 2018 Global Antibody-drug Conjugates Sales Share (%) by Players
Table Global Antibody-drug Conjugates Revenue (Million USD) by Players (2013-2018)
Table Global Antibody-drug Conjugates Revenue Share (%) by Players (2013-2018)
Table 2017 Global Antibody-drug Conjugates Revenue Share (%) by Players
Table 2018 Global Antibody-drug Conjugates Revenue Share (%) by Players
Table Global Market Antibody-drug Conjugates Average Price (USD/Pcs) by Players (2013-2018)
Table Global Antibody-drug Conjugates Top Players Manufacturing Base Distribution and Sales Area
Table Global Antibody-drug Conjugates Top Players Product Category
Figure Global Antibody-drug Conjugates Market Share (%) of Top 3 Players
Figure Global Antibody-drug Conjugates Market Share (%) of Top 5 Players
Table United States Antibody-drug Conjugates Sales (K Pcs) by Players (2013-2018)
Table United States Antibody-drug Conjugates Sales Market Share (%) by Players (2013-2018)
Figure 2017 United States Antibody-drug Conjugates Sales Share (%) by Players
Figure 2018 United States Antibody-drug Conjugates Sales Share (%) by Players
Table United States Antibody-drug Conjugates Revenue (Million USD) by Players (2013-2018)
Table United States Antibody-drug Conjugates Revenue Market Share (%) by Players (2013-2018)
Table 2017 United States Antibody-drug Conjugates Revenue Share (%) by Players
Table 2018 United States Antibody-drug Conjugates Revenue Share (%) by Players
Table United States Market Antibody-drug Conjugates Average Price (USD/Pcs) by Players (2013-2018)
Figure United States Antibody-drug Conjugates Market Share (%) of Top 3 Players
Figure United States Antibody-drug Conjugates Market Share (%) of Top 5 Players
Table ImmunoGen Basic Information List
Table ImmunoGen Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure ImmunoGen Antibody-drug Conjugates Sales Growth Rate (2013-2018)
Figure ImmunoGen Antibody-drug Conjugates Sales Global Market Share (%)(2013-2018)
Figure ImmunoGen Antibody-drug Conjugates Revenue Global Market Share (%)(2013-2018)
Table Seattle Genetics Basic Information List
Table Seattle Genetics Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Seattle Genetics Antibody-drug Conjugates Sales Growth Rate (2013-2018)
Figure Seattle Genetics Antibody-drug Conjugates Sales Global Market Share (%)(2013-2018)
Figure Seattle Genetics Antibody-drug Conjugates Revenue Global Market Share (%)(2013-2018)
Table Roche Basic Information List
Table Roche Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Roche Antibody-drug Conjugates Sales Growth Rate (2013-2018)
Figure Roche Antibody-drug Conjugates Sales Global Market Share (%)(2013-2018)
Figure Roche Antibody-drug Conjugates Revenue Global Market Share (%)(2013-2018)
Table Takeda Basic Information List
Table Takeda Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Takeda Antibody-drug Conjugates Sales Growth Rate (2013-2018)
Figure Takeda Antibody-drug Conjugates Sales Global Market Share (%)(2013-2018)
Figure Takeda Antibody-drug Conjugates Revenue Global Market Share (%)(2013-2018)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody-drug Conjugates
Figure Antibody-drug Conjugates Industrial Chain Analysis
Table Major Buyers of Antibody-drug Conjugates
Table Distributors/Traders List
Figure Global Antibody-drug Conjugates Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Global Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Figure United States Antibody-drug ConjugatesAntibody-drug Conjugates Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure United States Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global Antibody-drug Conjugates Sales (K Pcs) Forecast by Regions (2018-2025)
Figure Global Antibody-drug Conjugates Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America Antibody-drug Conjugates Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure North America Antibody-drug Conjugates Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe Antibody-drug Conjugates Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Europe Antibody-drug Conjugates Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Antibody-drug Conjugates Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Antibody-drug Conjugates Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America Antibody-drug Conjugates Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure South America Antibody-drug Conjugates Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Antibody-drug Conjugates Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Antibody-drug Conjugates Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global Antibody-drug Conjugates Sales (Million USD) Forecast by Type (2018-2025)
Figure Global Antibody-drug Conjugates Sales Market Share (%) Forecast by Type (2018-2025)
Table Global Antibody-drug Conjugates Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Antibody-drug Conjugates Revenue Market Share (%) Forecast by Type (2018-2025)
Table United States Antibody-drug Conjugates Sales (Million USD) Forecast by Type (2018-2025)
Figure United States Antibody-drug Conjugates Sales Market Share (%) Forecast by Type (2018-2025)
Table United States Antibody-drug Conjugates Revenue (Million USD) Forecast by Type (2018-2025)
Figure United States Antibody-drug Conjugates Revenue Market Share (%) Forecast by Type (2018-2025)
Table Global Antibody-drug Conjugates Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Antibody-drug Conjugates Sales Forecast by Application (2018-2025)
Table United States Antibody-drug Conjugates Sales (K Pcs) Forecast by Application (2018-2025)
Figure United States Antibody-drug Conjugates Sales Forecast by Application (2018-2025)
